Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Edwin E Jeng

2PUBLICATIONS

30CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Sep 17, 2024

A Phase I First-in-Human Study of ABBV-011, a Seizure-Related Homolog Protein 6-Targeting Antibody-Drug Conjugate, in Patients with Small Cell Lung Cancer.

Daniel Morgensztern, Neal Ready, Melissa L Johnson

|Jul 31, 2020

Combined Proteomic and Genetic Interaction Mapping Reveals New RAS Effector Pathways and Susceptibilities.

Marcus R Kelly, Kaja Kostyrko, Kyuho Han

Pageof 1

Frequent Collaborators

1 joint publications

Kaja Kostyrko

1 joint publications

Kyuho Han

1 joint publications

Keene L Abbott

1 joint publications

Daniel Morgensztern

1 joint publications

Neal Ready

1 joint publications

Melissa L Johnson

1 joint publications

Afshin Dowlati

1 joint publications

Noura Choudhury

1 joint publications

David P Carbone

1 joint publications

Eric Schaefer

Frequent Collaborators

1 joint publications

Kaja Kostyrko

1 joint publications

Kyuho Han

1 joint publications

Keene L Abbott

1 joint publications

Daniel Morgensztern

Top Related Videos

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on : Jul 17, 2019

See more related videos

Top Related Videos

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on : Jul 17, 2019

See more related videos